Citi Assumes 10X Genomics (TXG) at Neutral
Citi analyst Brendan Digan assumes coverage on 10X Genomics (NASDAQ: TXG) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
